by Alexander Fenkiw | Jan 31, 2025 | medical-software-whitepaper
The EU is now also regulating the use of artificial intelligence (AI) with the EU AI Act. This also affects manufacturers of software medical devices that integrate AI into their MDR medical devices. The AI Act is intended to ensure that AI systems are designed in a...
by Alexander Fenkiw | Jan 9, 2025 | Unkategorisiert
At the beginning of the development of a software medical device, the central question is: Which risk class applies to my product? Risk classification has serious implications and significantly influences the cost and time frame of product development. In extreme...
by Alexander Fenkiw | Oct 18, 2024 | medical-software-whitepaper
Are there still software medical devices in risk class I according to MDR? Are risk class I software products really being withdrawn from the market by regulatory authorities? Which federal state do I have to go to so that I can remain on the market with my class I...
by Alexander Fenkiw | Sep 18, 2024 | Unkategorisiert
On December 19, 2019, the Digital Supply Act (DVG) made it possible for doctors to be able to prescribe digital health applications (DiGA) to patients in a standardized way for the first time. Now a counterpart has also been created for nursing care: digital care apps...
by Alexander Fenkiw | Sep 10, 2024 | DiGA
Digital health applications (DiGA) require certificates for data security and data protection. Following repeated problems with the handling of personal data in some DiGAs in the past, manufacturers will have to have their applications checked more closely in future...